Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases)

[1]  A. Tincani,et al.  Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. , 2008, Rheumatology.

[2]  J. A. Robinson,et al.  Antiphospholipid antibody syndrome and autoimmune diseases. , 2008, Hematology/oncology clinics of North America.

[3]  E. Hachulla,et al.  Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients , 2008, Lupus.

[4]  M. Khamashta,et al.  A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. , 2007, Arthritis and rheumatism.

[5]  T. Barbui,et al.  Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. , 2007, Blood.

[6]  M. Petri,et al.  Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. , 2007, Arthritis and rheumatism.

[7]  D. Erkan.  Lupus and thrombosis. , 2006, The Journal of rheumatology.

[8]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[9]  M. Cerinic,et al.  Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases , 2005, Circulation.

[10]  J. Rodríguez-Martorell,et al.  Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. , 2004, The Journal of rheumatology.

[11]  P. Garred,et al.  Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. , 2004, The New England journal of medicine.

[12]  R. Roubey.  New approaches to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials, and tribulations. , 2003, Arthritis and rheumatism.

[13]  T. Barbui,et al.  Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. , 2003, Blood.

[14]  T. Barbui,et al.  Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. , 2003, Blood.

[15]  M. Peterson,et al.  A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. , 2002, Rheumatology.

[16]  M. Inanç,et al.  Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. , 2001, Blood.

[17]  J. Buyon,et al.  High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. , 2001, Arthritis and rheumatism.

[18]  F. Sarasin,et al.  Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. , 2000, Archives of internal medicine.

[19]  G. Hughes,et al.  Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients , 1998, Lupus.

[20]  T. Barbui,et al.  Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. , 1996, The American journal of medicine.

[21]  G. Hughes,et al.  The management of thrombosis in the antiphospholipid-antibody syndrome. , 1995, The New England journal of medicine.

[22]  P. D. de Groot,et al.  Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. , 1993, Annals of the rheumatic diseases.

[23]  M. Rosove,et al.  Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients , 1992, Annals of Internal Medicine.

[24]  A. Ruffatti,et al.  Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. , 2009, Thrombosis research.